Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, LAC + USC Medical Center, 1200 N State Street, GNH 3900, Los Angeles, CA 90033, USA.
Clin Orthop Relat Res. 2010 Aug;468(8):2107-12. doi: 10.1007/s11999-010-1271-2.
The literature contains variable reports on the causative organisms of osteomyelitis and septic arthritis in patients with injecting drug abuse and on the rate of oxacillin-resistant S aureus. It is important to have a clear notion of the organisms to initiate empiric antimicrobial therapy.
QUESTIONS/PURPOSES: We therefore determined the spectrum of organisms in bone and joint infections in patients who were injecting drug users.
We retrospectively reviewed the medical records of 215 patients (154 male, 61 female) with a history of injecting drug abuse and concurrent bone and/or joint infection from 1998 to 2005. The mean age was 43 years (range, 23-83 years). Osteomyelitis was present in 127 of the 215 patients (59%), septic arthritis in 53 (25%), and both in 35 (16%). The lower extremity was most commonly involved (141 cases, 66%), with osteomyelitis of the tibia present in 70 patients (33%) and septic knee arthritis in 30 patients (14%).
Cultures yielded predominately Gram-positive bacteria: Staphylococcus aureus in 52% and coagulase-negative Staphylococcus in 20%. The proportion of oxacillin-resistant S aureus among S aureus infections increased from 21% in 1998 to 73% in 2005. Gram-negative organisms were present in 19% of infections and anaerobes in 13%. Patients with osteomyelitis had a higher prevalence of polymicrobial infections (46% versus 15%), infections due to Gram-negative organisms (24% versus 9%), and anaerobic infections (19% versus 6%) compared to patients with septic arthritis.
These findings suggest broad-spectrum empiric antibiotic therapy, including vancomycin, should be considered for bone and joint infections in patients with injecting drug abuse.
Level IV, diagnostic study. See Guidelines for Authors for a complete description of levels of evidence.
文献中关于滥用注射药物患者骨髓炎和化脓性关节炎的病原菌以及耐苯唑西林金黄色葡萄球菌(oxacillin-resistant S aureus,简称 oxa-SA)的发生率报道存在差异。明确病原菌对于经验性抗菌治疗非常重要。
问题/目的:因此,我们确定了注射吸毒患者的骨关节感染的病原菌谱。
我们回顾性分析了 1998 年至 2005 年间 215 例(男 154 例,女 61 例)有注射吸毒史且并发骨和/或关节感染的患者的病历资料。平均年龄 43 岁(范围 23-83 岁)。215 例患者中 127 例(59%)患有骨髓炎,53 例(25%)患有化脓性关节炎,35 例(16%)同时患有这两种疾病。下肢最常受累(141 例,66%),其中胫骨骨髓炎 70 例(33%),化脓性膝关节炎 30 例(14%)。
培养物主要为革兰阳性菌:金黄色葡萄球菌占 52%,凝固酶阴性葡萄球菌占 20%。金黄色葡萄球菌感染中耐苯唑西林金黄色葡萄球菌的比例从 1998 年的 21%增加到 2005 年的 73%。19%的感染为革兰阴性菌,13%为厌氧菌。骨髓炎患者的混合感染率(46%比 15%)、革兰阴性菌感染率(24%比 9%)和厌氧菌感染率(19%比 6%)均高于化脓性关节炎患者。
这些发现提示对于滥用注射药物的骨关节感染患者,应考虑使用包括万古霉素在内的广谱经验性抗生素治疗。
IV 级,诊断研究。详见《作者指南》中对证据等级的完整描述。